Unity Biotechnology, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Unity Biotechnology, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2024.
  • Unity Biotechnology, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $11.4M, a 16% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $11.4M -$2.16M -16% Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $11.9M -$6.16M -34.1% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $12.4M -$6.12M -33% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $13M -$6.06M -31.8% Dec 31, 2023 10-Q 2024-11-04
Q3 2023 $13.5M -$5.99M -30.7% Sep 30, 2023 10-K 2024-04-15
Q2 2023 $18.1M -$2.06M -10.2% Jun 30, 2023 10-K 2024-04-15
Q1 2023 $18.6M -$2.15M -10.4% Mar 31, 2023 10-K 2024-04-15
Q4 2022 $19M -$2.24M -10.5% Dec 31, 2022 10-K 2024-04-15
Q3 2022 $19.5M -$2.34M -10.7% Sep 30, 2022 10-K 2024-04-15
Q2 2022 $20.1M -$2.3M -10.3% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $20.7M -$2.26M -9.85% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $21.3M -$2.22M -9.46% Dec 31, 2021 10-K 2023-03-15
Q3 2021 $21.9M -$2.47M -10.2% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $22.4M -$2.48M -9.94% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $23M -$2.48M -9.73% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $23.5M +$23.5M Dec 31, 2020 10-K 2022-03-15
Q3 2020 $24.3M Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $24.9M Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $25.4M Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $0 $0 Dec 31, 2019 10-K 2021-03-23
Q4 2018 $0 Dec 31, 2018 10-K 2021-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.